Published October 22, 2020
| Version v1
Patent
Open
METHODS OF TREATING CASTRATION-RESISTANT PROSTATE CANCER WITH GLUCOCORTICOID RECEPTOR ANTAGONISTS
Description
Embodiments of the invention are directed to the treatment of subjects with prostate cancer, in particular those with castration resistant prostate cancer, with glucocorticoid receptor antagonists. The prostate cancer may be one that has become resistant to androgen deprivation therapy, for example, by increase in glucocorticoid receptor expression and/or activity.
Files
US20200330482.pdf
Files
(1.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:107ac90dba18776639df8df472865968
|
1.3 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 202016913916 A
- Patent number
- US 2020/0330482 A1
- Other
- oai:uchicago.tind.io:8025
Dates
- Patent filed
-
2020-06-26